Tirzepatide vs Semaglutide in Australia: Regulatory & Evidence Comparison
These compounds have distinct regulatory and evidence considerations. A comparison does not recommend a treatment, establish suitability or predict outcomes.
Tirzepatide vs Semaglutide — head to head
| Attribute | Tirzepatide | Semaglutide |
|---|---|---|
| Mechanism | Dual GIP and GLP-1 receptor agonist | GLP-1 receptor agonist |
| Human evidence | Clinical studies relate to particular products and populations | Clinical studies relate to particular products and populations |
| Australian registration | ARTG-registered products; standard prescribing rules | ARTG-registered products; standard prescribing rules |
| PBS for weight management | PBS criteria change; check current official listings with your doctor. | PBS criteria change; check current official listings with your doctor. |
| Side-effect profile | Adverse effects, interactions and monitoring require individual clinical review. | Adverse effects, interactions and monitoring require individual clinical review. |
Verdict
Evidence limitations and individual safety require clinical assessment. Registration and lawful supply must be checked; this information is not a treatment recommendation.
Frequently asked questions
- What safety and evidence questions need assessment?
- Relevant questions include the quality of human studies, possible interactions, medical conditions that affect risk and gaps in long-term safety information.
- Which is cheaper in Australia?
- This educational comparison does not quote or compare medicine prices. Ask your doctor or pharmacist about any individual costs.
- Can these medicines be compounded in Australia?
- No. Compounded GLP-1 medicines, including semaglutide and tirzepatide, cannot be legally supplied in Australia since 1 October 2024. Only TGA-approved registered products are available on prescription, and a doctor assesses medical history, current medicines and clinical suitability before deciding whether a standard prescription for an ARTG-registered product is appropriate.
Read the full profiles
Other comparisons
Questions about clinical assessment
Questions about whether any treatment is right for you should be discussed with a registered doctor.
How Australian access pathways work All peptides